
INVESTIGATION OF CIRCULATING SERUM microRNA-328-3p
AND microRNA-3135a EXPRESSION AS PROMISING NOVEL
BIOMARKERS FOR AUTISM SPECTRUM DISORDER Popov NT, Minchev DS, Naydenov MM, Minkov IN, Vachev TI *Corresponding Author: Assistant Professor Tihomir I. Vachev, Ph.D., Department of Plant Phisyology
and Molecular Biology, University of Plovdiv “Paisii Hilendarski,” 24 Tzar Assen Str., Plovdiv, Bulgaria.
E-mail: tiho9@abv.bg page: 5
|
INTRODUCTION
MicroRNAs (miRNAs) are small, single-stranded,
non coding RNA molecules that regulate gene expression
of their complementary messenger RNA targets [1,2].
Taking into account, the significance of these regulatory
molecules in gene regulation, discovery of dysregulated
miRNAs could benefit to clarify the molecular differences
of miRNAs serum profiles between the autism spectrum
disorder (ASD) subjects and typically developing children
(TDC). The prevalence of ASD has increased considerably
(from 2-5/10,000 to 1:68 children) during the
last two decades [3,4]. Increased attention and changes
made to the diagnostic criteria by the medical community
have necessarily contributed to this tendency [5], as well
as several environmental factors, acting particularly over
early postnatal neurodevelopment and prenatal development
[6]. In addition, advanced parental age at time of
conception has also been shown to pose a risk of ASD
[7]. Despite major advances in the understanding of ASD
pathogenesis, inter individual heterogeneity and the levels of complexity has largely complicated the delivery of extensive
scientific learning into efficient clinical practices.
Currently, the golden standard to diagnose ASD is built
on information from several sources: family caregivers,
teachers, standardized behavioral scales and clinical observations.
Also, pervasive development of the patients is
only monitored by clinical scales with uncertain reliability,
especially in early age. Specific and sensitive quantitative
biomarkers, evaluated through experimental methods,
electrophysiological techniques and brain imaging, would
greatly support clinicians in providing more timely referrals
to behavioral intervention programs’ earlier diagnoses and
evidence-based prognosis [8]. Quantitative polymerase
chain reaction (qPCR) technologies offer a accurate tools to
search for specific miRNAs profiles applicable as potential
biomarkers for neurodevelopmental disorders. The choice
of miR-328-3p and miR-3135a as potential biomarkers
in ASD is based mainly on our preliminary data showing
differential expression changes of these miRNAs from
small RNA sequencing. In addition, there is no scientific
data on the role of these miRNAs in ASD, although the
importance of many miRNA molecules has been shown in
the etiopathogenesis of several neurological disorders. The
current study was performed in order to shed light on the
probable participation of miRNAs in ASD. The main aim of
the current research was to analyze differential expression
of miR-328-3p and miR-3135a in serum of ASD subjects
and their relevance as potential blood-based biomarkers.
|
|
|
|



 |
Number 27 VOL. 27 (2), 2024 |
Number 27 VOL. 27 (1), 2024 |
Number 26 Number 26 VOL. 26(2), 2023 All in one |
Number 26 VOL. 26(2), 2023 |
Number 26 VOL. 26, 2023 Supplement |
Number 26 VOL. 26(1), 2023 |
Number 25 VOL. 25(2), 2022 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|